Charles River Laboratories
627 hedge funds and large institutions have $10.3B invested in Charles River Laboratories in 2024 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 204 increasing their positions, 273 reducing their positions, and 97 closing their positions.
0.76% less ownership
Funds ownership: 101.73% → 100.97% (-0.76%)
5% less capital invested
Capital invested by funds: $10.8B → $10.3B (-$568M)
6% less funds holding
Funds holding: 664 → 627 (-37)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
25% less repeat investments, than reductions
Existing positions increased: 204 | Existing positions reduced: 273
32% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 97
38% less call options, than puts
Call options by funds: $59M | Put options by funds: $94.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$777M |
| 2 |
EC
Eminence Capital
New York
|
+$209M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$106M |
| 4 |
IC
Impactive Capital
New York City,
New York
|
+$78.2M |
| 5 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$62.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$177M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$107M |
| 3 |
SCA
Southpoint Capital Advisors
New York
|
-$99.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$97.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$67.2M |
CRL Hedge Fund Activity: Q3 2024 in Review
627 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2024, worth a combined $10.3B — down 5.2% from $10.8B a quarter earlier.
Sellers outnumbered buyers: 97 funds closed out of CRL and 66 opened new positions — a net loss of 31 holders — while 273 trimmed existing stakes and 204 added.
The largest buyer was Wellington Management Group, adding an estimated $777M. The largest seller was BlackRock, cutting an estimated $177M.
- 627 institutional investors held Charles River Laboratories (CRL) as of Q3 2024, down from 664 in Q2 2024.
- Funds reported $10.3B of Charles River Laboratories stock for Q3 2024, down 5.2% quarter-over-quarter.
- 66 funds opened new Charles River Laboratories positions in Q3 2024 and 97 closed out, a net change of -31 holders.
- The largest Charles River Laboratories buyer in Q3 2024 was Wellington Management Group, an estimated $777M added.
- The largest Charles River Laboratories seller in Q3 2024 was BlackRock, an estimated $177M sold.
Based on aggregated 13F filings for Q3 2024.